Medical Devices: Page 2
-
Boris Jovanovic via Getty Images
Beta Bionics wins FDA nod to challenge Medtronic for automated insulin pump market
Beta Bionics’ device, aimed at people with Type 1 diabetes, has eliminated most of the data entry required by competitors.
By Nick Paul Taylor • May 22, 2023 -
Stock via Getty Images
Abbott, Boston Scientific, Medtronic share data on heart rhythm devices at conference
A series of recent innovations in pacemaker technology has opened up new markets and set the stage for increased competition.
By Nick Paul Taylor • May 22, 2023 -
Explore the Trendline➔
Portra via Getty Images
TrendlineShifting Surgical Horizons and the Move to Outpatient Procedures
Medtech companies shift strategy as more orthopedic procedures move to ambulatory surgical centers.
By MedTech Dive staff -
Courtesy of Boston Scientific
A Boston Scientific purchase of Shockwave could be transformative — but at what price?
Boston Scientific has used “tuck-in” acquisitions to boost growth in the past. Some analysts say it should stay the course amid a report the company may make a bid.
By Susan Kelly • May 19, 2023 -
Stock Photo via Getty Images
Precision Lens ordered to pay $487M for kickbacks to eye surgeons in Medicare false-claims case
Luxury vacations and tickets to Broadway shows were used by the Minnesota-based ophthalmologic supply company to induce surgeons to use its products, a federal court ruled.
By Elise Reuter • May 19, 2023 -
Courtesy of Abbott
Abbott gains edge over cardiac monitor rivals with FDA clearance of 6-year device
Rival devices sold by Biotronik, Boston Scientific and Medtronic have battery lives ranging from three to 4.5 years.
By Nick Paul Taylor • May 19, 2023 -
Adam Berry via Getty Images
Chinese medtechs post data on renal denervation devices to rival Medtronic, ReCor
The findings validate the technique used by Medtronic and ReCor, while suggesting the U.S. companies will face competition if they target the Chinese market.
By Nick Paul Taylor • May 19, 2023 -
Courtesy of Abbott
Abbott shares data showing benefit of TriClip device amid FDA review
Patients experienced a reduction in tricuspid regurgitation and had improved heart function, according to late-breaking data presented at EuroPCR.
By Elise Reuter • May 18, 2023 -
Permission granted by J&J MedTech
J&J names Jasmina Brooks as president of Biosense Webster
Brooks will lead the company as J&J competes with rivals such as Boston Scientific over cardiac ablation technology.
By Nick Paul Taylor • May 18, 2023 -
Photo by MART Productions from Pexels
Clinical trials showcase potential roles for ultrasound in treating cancer, inflammatory disease
The use of ultrasound as a therapeutic device could lead to new treatment options. In one study, patients with brain tumors received an ultrasound implant that allowed a drug to enter the brain.
By Nick Paul Taylor • May 18, 2023 -
Permission granted by FastWave
OpinionTo lead in medtech, apply best practices from direct-to-consumer businesses
Entrepreneurs who are willing to leverage proven DTC strategies can gain a competitive advantage in medtech, argues Scott Nelson, president and CEO of FastWave Medical.
By Scott Nelson • May 17, 2023 -
ArtemisDiana via Getty Images
Rapid AI adoption could cause medical errors, patient harm, WHO warns, urging oversight
Warning that caution is not being exercised with use of artificial intelligence in healthcare, the World Health Organization called for rigorous oversight of the new technology.
By Susan Kelly • May 17, 2023 -
Courtesy of Masimo
ITC to review ruling that Apple violated Masimo’s patents
If the ITC finds Apple improperly used Masimo’s pulse oximetry technology in the Apple Watch, the commission could ban imports of some Watch versions.
By Elise Reuter • May 17, 2023 -
Courtesy of Abbott Laboratories
Abbott wins FDA spinal cord stimulation approval to challenge Nevro for back pain market
The label expansion comes 16 months after Nevro won FDA approval in non-surgical refractory back pain and four months after Boston Scientific released data on its rival device.
By Nick Paul Taylor • Updated May 17, 2023 -
Courtesy of Philips
Philips claims exposure to foam particles in recalled sleep apnea devices unlikely to harm patients
Inhaling foam particles or chemicals from the recalled devices is unlikely to significantly harm patients, Philips argued, but it added that regulators may reach a different conclusion.
By Elise Reuter • Updated May 16, 2023 -
Permission granted by Intuitive Surgical
Intuitive Surgical promotes Dave Rosa to president, Guthart remains CEO
The surgical robot maker said longtime CEO Gary Guthart retains his role and will continue to lead the company.
By Susan Kelly • May 16, 2023 -
Tarathip Kwankeeree via Getty Images
Cook Medical lays off 500 after ‘significant change’ to operating environment
In a memo to employees, CEO Pete Yonkman said that hourly manufacturing and distribution workers won’t be laid off because demand for Cook Medical’s products “continues to grow.”
By Nick Paul Taylor • May 16, 2023 -
Courtesy of Verily
Diabetes app developers must generate more data on clinical effectiveness, study says
The researchers saw a need for more data on the wider clinical effectiveness of apps in the management of Type 1 diabetes and prediabetes.
By Nick Paul Taylor • May 16, 2023 -
Permission granted by Embecta
Embecta joins Tidepool to develop insulin pump, raises Q2 growth outlook
Embecta advanced its pump project by partnering with Tidepool, a nonprofit that has developed diabetes management software that can work across different brands of pumps and monitors.
By Nick Paul Taylor • May 15, 2023 -
Courtesy of GE HealthCare
GE HealthCare’s order book raises questions about sales-growth potential, analysts say
BTIG analysts found “lower order growth than what is assumed” and shared concern the medtech company may face challenges just four months after it was spun off from parent General Electric.
By Nick Paul Taylor • May 12, 2023 -
Gromit702/iStock/Getty Images Plus via Getty Images
AdvaMed cites EPA’s own impact assessment to push back against ethylene oxide proposals
Medtech firms and environmental regulators are at loggerheads as the industry looks for a safe and cost-effective alternative to ethylene oxide for sterilizing reusable devices.
By Nick Paul Taylor • May 12, 2023 -
Neilson Barnard via Getty Images
Icahn wins proxy firm nod to oust CEO from Illumina board
The recommendation from Glass Lewis is a boost for Icahn’s plan to force change at the DNA sequencer, as he and Illumina’s management battle for proxies ahead of a shareholder vote on May 25.
By Elise Reuter • May 11, 2023 -
Stock via Getty Images
Google adds image analysis capabilities to generative AI model, enabling dialogues with doctors
The Med-PaLM 2 has the ability to review X-rays and mammograms, write reports about images and respond to follow-up questions from caregivers.
By Nick Paul Taylor • May 11, 2023 -
Courtesy of Nuvasive
NuVasive grows sales in Q1, allaying concerns about impact of $3.1B Globus merger
The growth reflects “increased procedure volumes” and a “continued surge in demand” for NuVasive devices.
By Nick Paul Taylor • May 11, 2023 -
Courtesy of GuardantHealth
Guardant blood test detects 83% of colorectal cancer cases, but fewer in early stage
Analysts said the test is likely to meet the bar for FDA approval, but its flaws in detecting early-stage cancer weaken its chances against Exact Sciences’ stool-based test, Cologuard.
By Elise Reuter • May 10, 2023 -
Patrik Stollarz / Staff via Getty Images
Philips loses vote as shareholders push back against handling of respirator recall
The vote will allow investors to sue board members over their actions in 2022. Philips blamed the ballot loss on guidance from proxy advisors.
By Nick Paul Taylor • May 10, 2023
Previous
